Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-05 Sale | 2024-03-07 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 4,135 | $18.73 | $77,440 | 3,023,002 (Direct) | View |
| 2024-01-09 Sale | 2024-01-11 5:10 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 5,841 | $16.33 | $95,372 | 2,900,470 (Direct) | View |
| 2023-03-16 Sale | 2023-03-20 8:21 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 100,000 | $31.86 | $3,186,336 | 3,067,617 (Direct) | View |
| 2023-01-06 Sale | 2023-01-10 7:20 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 5,968 | $36.3 | $216,629 | 2,892,617 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-16 Option Award | 2024-04-18 8:21 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 559,850 | $0 | 3,582,852 (Direct) | View |
| 2024-02-26 Option Award | 2024-02-28 6:22 pm | N/A 2034-02-25 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 316,667 | $0 | 3,217,137 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 8:20 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 63,694 | $1.57 | 2,942,617 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 8:20 pm | N/A 2025-02-26 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 63,694 | $0 | 2,942,617 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-20 8:21 pm | N/A 2033-03-16 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 275,000 | $0 | 3,067,617 (Direct) | View |
| 2022-05-05 Exercise | 2022-05-06 4:05 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 334,520 | $0.37 | 2,898,585 (Direct) | View |
| 2022-05-05 Exercise | 2022-05-06 4:05 pm | N/A 2023-02-16 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 334,520 | $0 | 2,898,585 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 8:32 pm | N/A 2032-01-06 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 412,500 | $0 | 2,901,565 (Direct) | View |
| 2022-01-06 Conversion | 2022-01-10 8:32 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 4,870 | $0 | 2,901,565 (Direct) | View |
Ownership | 2022-01-06 5:10 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 0 | $0 | 3,123,585 (Direct) | View |